Interferon-modulated vaccines against HIV

NIH RePORTER · NIH · DP2 · $81,547 · view on reporter.nih.gov ↗

Abstract

Project Summary The main goal of the parent grant is to develop interferon-modulated vaccines against HIV. The proposed research will follow up on the same unifying concept of our parent DP2 grant, but in addition, it will consider the effect of boosting with a heterologous vaccine. Bakare has observed that boosting with a heterologous vaccine regimen enhances the efficacy of vaccines (manuscript in preparation). The preliminary data shown below is with SARS-CoV-2 vaccines, but it demonstrates a potentially novel and universal strategy to improve viral vaccines against HIV and other infectious agents that affect PWID. Improving vaccine efficacy is also critical to improve the lives of PWID.

Key facts

NIH application ID
10815447
Project number
3DP2DA051912-01S2
Recipient
NORTHWESTERN UNIVERSITY
Principal Investigator
Pablo Penaloza-MacMaster
Activity code
DP2
Funding institute
NIH
Fiscal year
2023
Award amount
$81,547
Award type
3
Project period
2020-07-01 → 2024-06-30